astrazeneca 'within striking distance' of curing some cancers, ceo says | cnbc conversation
Published 4 years ago • 2.7K plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
3:46
pharma industry has a trust issue, astrazeneca ceo says | cnbc conversation
-
5:22
the new uk government needs to think long term and fund the nhs and research, astrazeneca ceo says
-
8:42
astrazeneca ceo pascal soriot goes one-on-one with jim cramer
-
5:03
astrazeneca ceo: objective is to replace chemotherapy
-
4:11
astrazeneca ceo pascal soriot on progress on pancreatic cancer
-
0:53
positive lung cancer results show our strategy is working: astrazeneca
-
3:22
astrazeneca ceo pascal soriot breaks down data on new 'transformative' breast cancer drug
-
5:38
patients are returning and we see a good third quarter ahead, says astrazeneca ceo
-
4:31
astrazeneca's evp on the potential of the pharma giant's new breast cancer drug
-
0:54
pfizer ceo: cancer drugs will be our next big contribution to the world
-
3:22
astrazeneca: fusion acquisition will be a cost effective-investment that can improve cancer outcomes
-
3:31
we expect slight decline in china due to price pressures, astrazeneca ceo says
-
4:08
astrazeneca chairman: making vaccines is one thing, but we need to make sure they get distributed
-
4:55
astrazeneca ceo soriot speaks on $6.9 billion cancer therapy deal
-
1:28
tpg's co-ceo on impact investing | cnbc conversation
-
3:44
not clear yet if we need a third booster for the vaccine: astrazeneca ceo
-
1:35
astrazeneca ceo: we've increased inventory levels ahead of brexit | street signs europe
-
2:04
brexit preparations have cost £40 million to £50 million: astrazeneca ceo | street signs europe